Larimar Therapeutics Ownership | Who Owns Larimar Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Larimar Therapeutics Ownership Summary


Larimar Therapeutics is owned by 130.57% institutional investors, 1.07% insiders. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 47.80% of LRMR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.28% of its assets in Larimar Therapeutics shares.

LRMR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLarimar Therapeutics130.57%1.07%-31.64%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deerfield management company, l.p. (series c)30.61M47.80%$98.86M
Ra capital management6.05M9.44%$19.53M
Blue owl capital lp5.85M9.14%$18.91M
Blackrock3.13M5.85%$22.72M
Opaleye management3.72M5.81%$10.56M
Blackrock funding, inc. /de3.34M5.22%$10.79M
Rtw investments, lp3.13M4.88%$10.09M
Vanguard group3.09M4.82%$9.97M
Adage capital partners gp1.90M2.97%$6.14M
Alyeska investment group1.89M2.95%$6.10M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp5.85M5.87%$18.91M
Deerfield management company, l.p. (series c)30.61M1.51%$98.86M
Opaleye management3.72M1.49%$10.56M
Aigh capital management1.00M0.91%$3.23M
Dafna capital management1.03M0.82%$3.32M
Altium capital management lp505.00K0.55%$1.95M
Ra capital management6.05M0.24%$19.53M
Sphera funds management260.38K0.18%$841.04K
Rtw investments, lp3.13M0.12%$10.09M
Mangrove partners442.24K0.11%$1.43M

Top Buyers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)30.61M1.51%9.38M
Rtw investments, lp3.13M0.12%3.13M
Adage capital partners gp1.90M0.01%1.90M
Goldman sachs group1.58M0.00%1.44M
Point72 asset management1.22M0.01%1.22M

Top Sellers

HolderShares% AssetsChange
Janus henderson group---5.57M
Two sigma advisers, lp252.37K0.00%-894.55K
Two sigma investments, lp134.73K0.00%-768.88K
Fred alger management---737.55K
Stempoint capital lp---704.35K

New Positions

HolderShares% AssetsChangeValue
Rtw investments, lp3.13M0.12%3.13M$10.09M
Adage capital partners gp1.90M0.01%1.90M$6.14M
Point72 asset management1.22M0.01%1.22M$3.95M
Aigh capital management1.00M0.91%1.00M$3.23M
Hap trading262.78K0.06%262.78K$848.77M

Sold Out

HolderChange
National bank of canada /fi/-2.00
Ifp advisors-4.00
Nelson, van denburg & campbell wealth management group-5.00
Quadrant capital group-14.00
Capital performance advisors llp-18.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202514724.58%83,602,86738.89%1301.47%8722.54%2623.81%
Jun 30, 202512418.10%62,303,7192.43%971.08%7250.00%24-22.58%
Mar 31, 202510-91.80%31,178,885-50.84%480.49%5-92.19%1-97.14%
Dec 31, 2024116-8.66%61,296,513-4.71%960.95%61-6.15%32-5.88%
Sep 30, 202412715.45%64,329,114-1.50%1000.68%654.84%34-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.95M2.28%645.43K
Vanguard US Total Market Shares ETF1.34M2.10%-
iShares Russell 2000 ETF1.07M1.25%-
Fidelity Advisor Biotechnology I524.80K0.82%-
Invesco Dorsey Wright SmallCap Momt ETF422.53K0.66%-
Alger Small Cap Growth B398.96K0.62%-
Heptagon Driehaus US Micro Cap Eq C$ Acc387.15K0.61%-2.69K
iShares Russell 2000 Growth ETF388.03K0.61%-
Janus Henderson Hrzn Biotec E2 USD347.56K0.54%-107.54K
Fidelity Small Cap Index427.25K0.50%-10.62K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 31, 2025Flynn James E * Director by DeputizationBuy$10.84M
Jul 31, 2025Flynn James E * Director by DeputizationBuy$8.32M
Jul 31, 2025Flynn James E * Director by DeputizationBuy$10.84M
Feb 16, 2024Hamilton Thomas Edward-Buy$500.00K
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q2--
2024 Q15-
2023 Q41-

LRMR Ownership FAQ


Who Owns Larimar Therapeutics?

Larimar Therapeutics shareholders are primarily institutional investors at 130.57%, followed by 1.07% insiders and -31.64% retail investors. The average institutional ownership in Larimar Therapeutics's industry, Biotech Stocks , is 45.22%, which Larimar Therapeutics exceeds.

Who owns the most shares of Larimar Therapeutics?

Larimar Therapeutics’s largest shareholders are Deerfield management company, l.p. (series c) (30.61M shares, 47.80%), Ra capital management (6.05M shares, 9.44%), and Blue owl capital lp (5.85M shares, 9.14%). Together, they hold 66.39% of Larimar Therapeutics’s total shares outstanding.

Does Blackrock own Larimar Therapeutics?

Yes, BlackRock owns 5.85% of Larimar Therapeutics, totaling 3.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 795.19K shares, a 34.00% change.

Who is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.87% of its assets in 5.85M Larimar Therapeutics shares, valued at 18.91M$.

Who is the top mutual fund holder of Larimar Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Larimar Therapeutics shares, with 2.28% of its total shares outstanding invested in 1.95M Larimar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools